GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Allergan PLC (FRA:A60) » Definitions » Price-to-Free-Cash-Flow

Allergan (FRA:A60) Price-to-Free-Cash-Flow : 11.56 (As of Apr. 26, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Allergan Price-to-Free-Cash-Flow?

As of today (2024-04-26), Allergan's share price is €179.14. Allergan's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2020 was €15.49. Hence, Allergan's Price-to-Free-Cash-Flow Ratio for today is 11.56.

The historical rank and industry rank for Allergan's Price-to-Free-Cash-Flow or its related term are showing as below:

FRA:A60' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 7.38   Med: 18.86   Max: 301.76
Current: 11.22

During the past 13 years, Allergan's highest Price-to-Free-Cash-Flow Ratio was 301.76. The lowest was 7.38. And the median was 18.86.

FRA:A60's Price-to-Free-Cash-Flow is not ranked
in the Drug Manufacturers industry.
Industry Median: 21.89 vs FRA:A60: 11.22

Allergan's Free Cash Flow per Share for the three months ended in Mar. 2020 was €-0.00. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was €15.49.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of Allergan was 12.70% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was 92.70% per year. During the past 5 years, the average Free Cash Flow per Share Growth Rate was 22.20% per year. During the past 10 years, the average Free Cash Flow per Share Growth Rate was 19.80% per year.

During the past 13 years, Allergan's highest 3-Year average Free Cash Flow per Share Growth Rate was 160.90% per year. The lowest was -23.10% per year. And the median was 15.10% per year.


Allergan Price-to-Free-Cash-Flow Historical Data

The historical data trend for Allergan's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Allergan Price-to-Free-Cash-Flow Chart

Allergan Annual Data
Trend Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only 29.76 76.45 10.66 8.36 9.23

Allergan Quarterly Data
Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 9.59 10.66 8.32 9.23 10.30

Competitive Comparison of Allergan's Price-to-Free-Cash-Flow

For the Drug Manufacturers - General subindustry, Allergan's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Allergan's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Allergan's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Allergan's Price-to-Free-Cash-Flow falls into.



Allergan Price-to-Free-Cash-Flow Calculation

Allergan's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=179.14/15.492
=11.56

Allergan's Share Price of today is €179.14.
Allergan's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2020 adds up the quarterly data reported by the company within the most recent 12 months, which was €15.49.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

Allergan  (FRA:A60) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


Allergan Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Allergan's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Allergan (FRA:A60) Business Description

Traded in Other Exchanges
N/A
Address
Clonshaugh Business and Technology Park, Coolock, Dublin, IRL, D17E400
Allergan PLC is one of the largest specialty pharmaceutical manufacturers. It specializes in aesthetics, ophthalmology, women's health, gastrointestinal, and central nervous system products. The products offered by the company include Botox, Celexa, Fetzima, Refresh, Ozurdex and Zenpep among others.

Allergan (FRA:A60) Headlines

No Headlines